What's New

Immuno Cure Successfully Admitted into the HKSTP Elite Programme

Remarkable funding support for becoming a biotech unicorn HONG KONG SAR – Media OutReach Newswire – 26 June 2024 – Immuno Cure BioTech (“Immuno Cure“) is delighted to announce its recent successful admission to the prestigious Elite Programme of Hong Kong Science & Technology Park (“HKSTP“), positioning the company for […]